Association between immune-related adverse events and prognosis after immune checkpoint inhibitor in hepatocellular carcinoma: A meta-analysis and systematic review.

被引：0
|
作者：
Hwang, Soo Young
Rezaee-Zavareh, Mohammad Saeid
Attia, Abdelrahman M.
Kaymen, Emily
Tran, Nguyen H.
Abou-Alfa, Ghassan K.
Singal, Amit
Yang, Ju Dong
机构：
[1] Univ Maryland, Midtown Campus, Baltimore, MD USA
[2] Middle East Liver Dis MELD Ctr, Tehran, Iran
[3] Cedars Sinai Med Ctr, Karsh Div Gastroenterol & Hepatol, Comprehens Transplant Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA USA
[4] Cedars Sinai Med Ctr, Dept Oncol, Los Angeles, CA USA
[5] Mayo Clin Rochester, Dept Oncol, Rochester, MN USA
[6] Mem Sloan Kettering Canc Ctr, New York, NY USA
[7] Univ Texas SouthWestern Med Ctr, Dept Internal Med, Dallas, TX USA
[8] Cedars Sinai Med Ctr, Karsh Div Gastroenterol & Hepatol, Los Angeles, CA USA
[9] Cedars Sinai Med Ctr, Comprehens Transplant Ctr, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.566
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
566
引用
收藏
页码：566 / 566
页数：1
相关论文
共 50 条
  • [1] Association between immune-related adverse events and prognosis in immune checkpoint inhibitor therapy: A bibliometric and visual analysis
    Zhao, Jun
    Quan, Xianghua
    Liang, Yu
    Ni, Beibei
    Xing, Xiaomin
    Liu, Guangwei
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2025, 21 (01)
  • [2] Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis
    Oliveira, Clara
    Mainoli, Beatrice
    Duarte, Goncalo S.
    Machado, Tiago
    Tinoco, Rita G.
    Esperanca-Martins, Miguel
    Ferreira, Joaquim J.
    Costa, Joao
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 80 (05) : 677 - 684
  • [3] Monocyte-related markers as predictors of immune checkpoint inhibitor efficacy and immune-related adverse events: a systematic review and meta-analysis
    Ezdoglian, Aiarpi
    Tsang-A-Sjoe, Michel
    Khodadust, Fatemeh
    Burchell, George
    Jansen, Gerrit
    de Gruijl, Tanja
    Labots, Mariette
    van der Laken, Conny J.
    CANCER AND METASTASIS REVIEWS, 2025, 44 (01)
  • [4] Body mass index and immune-related adverse events in patients on immune checkpoint inhibitor therapies: a systematic review and meta-analysis
    Yuli Guzman-Prado
    Jennifer Ben Shimol
    Ondrej Samson
    Cancer Immunology, Immunotherapy, 2021, 70 : 89 - 100
  • [5] Body mass index and immune-related adverse events in patients on immune checkpoint inhibitor therapies: a systematic review and meta-analysis
    Guzman-Prado, Yuli
    Ben Shimol, Jennifer
    Samson, Ondrej
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (01) : 89 - 100
  • [6] Meta-analysis of immune-related adverse events of immune checkpoint inhibitor therapy in cancer patients
    Song, Peng
    Zhang, Dingding
    Cui, Xiaoxia
    Zhang, Li
    THORACIC CANCER, 2020, 11 (09) : 2406 - 2430
  • [7] A bibliometric analysis of immune-related adverse events in cancer patients and a meta-analysis of immune-related adverse events in patients with hepatocellular carcinoma
    Wang, Bengang
    Hao, Xiangjun
    Yan, Jinshan
    Li, Xin
    Zhao, Mingfang
    Han, Tao
    JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE, 2024, 12 (03) : 225 - 243
  • [8] Correlation Between Immune-Related Adverse Events and Prognosis in Hepatocellular Carcinoma Patients Treated With Immune Checkpoint Inhibitors
    Xu, Shuo
    Lai, Ruixue
    Zhao, Qian
    Zhao, Pandong
    Zhao, Ruili
    Guo, Zhanjun
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [9] Incidence of Cutaneous Immune-Related Adverse Events and Outcomes in Immune Checkpoint Inhibitor-Containing Regimens: A Systematic Review and Meta-Analysis
    Curkovic, Nina B.
    Bai, Kun
    Ye, Fei
    Johnson, Douglas B.
    CANCERS, 2024, 16 (02)
  • [10] Association between immune-related adverse events and efficacy of immune checkpoint inhibitors in patients with advanced hepatocellular carcinoma
    Wong, L.
    Ang, A.
    Ng, K.
    Tan, S. H.
    Choo, S. P.
    Tai, D.
    Lee, J.
    ANNALS OF ONCOLOGY, 2019, 30
12345